Optibiotix Health Plc
Company Profile
OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.

Latest Company Summary
Investor Access
Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Thursday, 17 November 2022 at 12:00 providing an update on the commercial strategy and future plans for the Company. Investors can sign up to Investor Meet Company for free, by clicking here.
Event | Date |
Year End | 31 December |
Half Year End | 30 June |
Preliminary Results* | May |
Interim Results* | September |
AGM* | July |
* Months based on previous announcements of this kind